Virax Biolabs Group Ltd. Class A
(NASDAQ: VRAX)

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

0.182 -

+0.005 (+2.82%)
Range 0.171 - 0.188   (9.94%)
Open 0.180
Previous Close 0.177
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 1,047,451
Value 115,211
Remark -
Delayed prices. Updated at 12 Jun 2026 08:15.
Data powered by
View All Events


Top Contributors

JonWick38 avatar
11679
Followers 278
Posts 2529

Loading Chart...

Please login to view stock data and analysis